DTAB approves Sub-committee Report Suggesting Prohibition of 16 FDCs

A report from the Drugs Technical Advisory Board's (DTAB) subcommittee, led by Dr. Nilima Kshirsagar, found 16 fixed dose combinations (FDCs) to be irrational and suggested that they be banned because they could endanger human health. The DTAB concur

DCA Raids in Telangana Uncover Banned, Expired Drugs in Hospitals

During a massive crackdown across Telangana, Drug Control Administration (DCA) officials raided 66 pharmacies linked to corporate hospitals; they found a mass violation of regulations including sale of...

Senores Pharmaceuticals Acquires USFDA-Approved ANDA for Tramadol Tablets

Senores Pharmaceuticals Limited, a world class research based pharmaceutical firm has made a disclosure that its 100% owned subsidiary...

FDC Ltd Recalls Over 60,000 Bottles of Ophthalmic Solution in US

FDC Ltd, a drug company from Mumbai, has had to recall more than 60,000 bottles of Timolol Maleate Ophthalmic Solution USP across the US. The trouble started when they found out the bottles were faulty the cap’s spike was getting jammed in the noz...

Generic Versions of Major Diabetes Medication Surges in Market

Empagliflozin, a widely used diabetes medication, after two weeks, went off patent.

Zydus Gets USFDA Approval for Glatiramer Acetate, Copaxone Generic

Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL...

Mounjaro Gains Ground in Competitive Weight-Loss Arena

PharmaTrac, a market research firm, published data on Eli Lilly’s weight-loss drug Mounjaro has seen rapid growth in India just a month after its launch, with sales of the 2.5 mg injection jumping from Rs. 1.42 crore in March to Rs. 4.8 crore in Apri

New Schedule M Requirements Pose Challenge for Drug Manufacturers

According to Health Ministry officials, there are about 10,000 medium and small manufacturing businesses and only 100 of them submitted applications.

NPPA Caps Prices of 84 Drug Combinations, Including Empagliflozin Variants

The National Pharmaceutical Pricing Authority (NPPA) has set 84 drug formulations' retail prices, including 36 formulations of empagliflozin, a diabetes drug that was originally developed by German firm Boehringer Ingelheim...

FDCA Gujarat Acts Against Illegal Psychotropic Drug Sales

A significant attempt to stop illegal sale of narcotic and psychotropic drugs has been made by the Gujarat Food and Drugs Control Administration (FDCA) in a major crackdown effort on the illicit sale of drugs in the state...

© 2025 India Pharma Outlook. All Rights Reserved.